DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Trifluperidol
Trifluperidol
2D6 Substrates 2D6 Inhibitors 2D6 Inducers
Current Biological Treatments of Schizophrenia
Appendix 13C: Clinical Evidence Study Characteristics Tables
The Effects of Antipsychotic Treatment on Metabolic Function: a Systematic Review and Network Meta-Analysis
Antipsychotics (Part-4) FLUOROBUTYROPHENONES
(12) United States Patent (10) Patent No.: US 6,197,764 B1 Bradley Et Al
(12) Patent Application Publication (10) Pub. No.: US 2006/00398.69 A1 Wermeling Et Al
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Placebo Response in Antipsychotic Clinical Trials a Meta-Analysis
Antipsychotics-Children-Surveillance
Haloperidol Injection, Usp
Electronic Search Strategies
Haloperidol Decreases the Turnover of GABA in the Striatum, Whereas Clozapine Increases the Turnover of GABA in the Substantia Nigra
New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
Extrapyramidal Symptoms Often Arise During Psychiatric Therapy with Neuroleptics
Uniform Classification Guidelines for Foreign Substances, Version 7.00
Neuroleptics and Microglial Activation Associated with Neuropsychiatric Disorders
Butler. K ...99 Juby. P . F ...208 Kaiser. C ...6. 18
Top View
Avoidance of Dopamine-Blocking Medications in Patients with Parkinson's Disease
PRODUCT MONOGRAPH Pr Haloperidol Decanoate Injection
Informationen Zur
Generation Antipsychotics for Children and Young Adults Comparative Effectiveness Review Number 39
Chlorpromazine for Schizophrenia: a Cochrane Systematic Review of 50 Years of Randomised Controlled Trials
Pharmacogenetics of Antidepressants and Antipsychotics
Example List of Forbidden Substances
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Antipsychotic Drugs Which Elicit Little Or No Parkinsonism Bind More Loosely
Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
United States Patent (19) 11 Patent Number: 5,955,459 Bradley Et Al
Chlorpromazine Versus Placebo for Schizophrenia
Drugs and Medications
Sigma Receptor-Mediated Alterations in Cellular Morphology and Viability
Neuroleptic Binding Sites: Specific Labeling in Mice with [18]Haloperidol, A
Changes in Serum TNF-Α, IL-18, and IL-6 Concentrations in Patients with Chronic Schizophrenia at Admission and at Discharge
2020 AQHA Guidelines and Rules for Drugs and Medications
Antipsychotic Drugs
Comparison of Glycemic and Metabolic Control
Parkinson's Disease Quality Measurement Set Update
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Product Monograph
Comparison of Glycemic and Metabolic Control
Neuroleptika
Product Monograph